Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6a43bee2d208c802be053f9d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg",
"description": "Managing type 2 diabetes often requires more than a single medication to achieve long-term blood sugar control. Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a triple-combination prescription medicine formulated to help adults with type 2 diabetes maintain healthy glucose levels when diet, exercise, and single-drug therapy are not enough.\n\nThis advanced combination works through three different mechanisms to improve insulin sensitivity, reduce glucose production by the liver, and enhance the body's natural insulin response after meals. Because of its multi-action approach, it is frequently prescribed by healthcare professionals for patients requiring comprehensive glycemic control.\n\nIf you are searching for Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg, this guide covers everything you need to know—including how it works, benefits, dosage information, side effects, precautions, storage, and frequently asked questions.\n\nWhat is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a prescription oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus. It combines three clinically proven medicines into one convenient tablet to provide better blood sugar management throughout the day.\n\nThe formulation contains:\n\nSitagliptin 100 mg – A DPP-4 inhibitor that increases incretin hormones to improve insulin secretion.\nMetformin Hydrochloride 1000 mg Sustained Release – A biguanide that lowers glucose production by the liver and improves insulin sensitivity.\nPioglitazone 15 mg – A thiazolidinedione that enhances the body's response to insulin.\n\nTogether, these ingredients target multiple causes of high blood sugar, helping patients achieve better diabetes control while reducing the need for multiple separate medications.\n\nHow Does Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg Work?\n\nThis triple-combination tablet works through complementary mechanisms:\n\n1. Sitagliptin\n\nSitagliptin inhibits the DPP-4 enzyme, allowing incretin hormones to remain active longer. These hormones increase insulin release after meals and reduce excess glucagon production.\n\n2. Metformin SR\n\nMetformin Sustained Release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity without causing excessive insulin release.\n\n3. Pioglitazone\n\nPioglitazone improves insulin sensitivity in muscle and fat tissues, enabling cells to utilize glucose more effectively.\n\nThe combination helps maintain consistent blood sugar levels throughout the day while lowering both fasting and post-meal glucose.\n\nWhy is This Triple Combination Important?\n\nType 2 diabetes progresses over time, making it difficult for many patients to control blood sugar using a single medication. A triple therapy offers several advantages:\n\nBetter HbA1c reduction\nMultiple mechanisms of action\nReduced insulin resistance\nImproved post-meal glucose control\nLower fasting blood sugar\nSimplified treatment with one tablet\nImproved medication adherence\nReduced need for additional medications\n\nHealthcare providers often prescribe this combination when dual therapy no longer provides adequate glucose control.\n\nKey Benefits of Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\nExcellent Blood Sugar Control\n\nThe medicine helps reduce both fasting and postprandial blood glucose levels effectively.\n\nTriple Mechanism of Action\n\nEach ingredient targets a different pathway involved in diabetes, resulting in more comprehensive glycemic control.\n\nImproved Insulin Sensitivity\n\nPioglitazone increases insulin responsiveness, helping the body utilize glucose more efficiently.\n\nReduced Liver Glucose Production\n\nMetformin decreases glucose release from the liver, preventing unnecessary increases in blood sugar.\n\nSupports Long-Term Diabetes Management\n\nRegular use, alongside lifestyle modifications, contributes to improved HbA1c levels and reduced diabetes-related complications.\n\nConvenient Once-Daily Regimen\n\nCombining three medicines into a single tablet improves treatment convenience and supports better compliance.\n\nWho May Benefit from This Medicine?\n\nHealthcare professionals may prescribe this medication for adults with Type 2 Diabetes who:\n\nHave uncontrolled blood sugar despite dual therapy\nRequire triple oral anti-diabetic therapy\nHave elevated HbA1c levels\nNeed improved insulin sensitivity\nPrefer fewer tablets in their treatment plan\nAre following dietary and exercise recommendations but require additional glucose control\n\nThis medicine is not intended for Type 1 Diabetes or diabetic ketoacidosis.\n\nHow to Take Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\n\nAlways follow your physician's instructions.\n\nGeneral recommendations include:\n\nTake once daily or as prescribed.\nSwallow the tablet whole.\nDo not crush, split, or chew the sustained-release tablet.\nTake with food to reduce stomach discomfort.\nTake it at the same time each day.\nContinue exercising and following a diabetic meal plan.\n\nNever stop treatment without consulting your healthcare provider.\n\nPossible Side Effects\n\nLike all prescription medicines, this combination may cause side effects, although not everyone experiences them.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nDiarrhea\nHeadache\nUpper respiratory infection\nWeight gain\nSwelling of feet or ankles\nMuscle aches\nDizziness\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reaction\nPersistent vomiting\nDifficulty breathing\nSevere abdominal pain\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of lactic acidosis\nSigns of heart failure, such as rapid weight gain or shortness of breath\nPrecautions Before Using This Medicine\n\nInform your healthcare provider if you have:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer history\nPancreatitis\nSevere dehydration\nAlcohol dependence\nVitamin B12 deficiency\nPlanned surgery or imaging with contrast dye\n\nWomen who are pregnant or breastfeeding should use this medicine only under medical supervision.\n\nDrug Interactions\n\nTell your doctor about all medicines you take, including:\n\nInsulin\nSulfonylureas\nDiuretics\nCorticosteroids\nThyroid medicines\nBlood pressure medicines\nRifampicin\nAlcohol\nCimetidine\nCertain antifungal medicines\n\nProper medication review helps minimize interaction risks.\n\nLifestyle Tips for Better Diabetes Control\n\nMedicine works best when combined with healthy lifestyle habits.\n\nRecommended practices include:\n\nFollow a balanced diabetic diet.\nExercise for at least 30 minutes most days.\nMonitor blood sugar regularly.\nMaintain a healthy body weight.\nStay hydrated.\nAvoid smoking.\nLimit alcohol intake.\nGet regular HbA1c tests.\nManage stress effectively.\nAttend routine medical check-ups.\nStorage Instructions\n\nStore the tablets:\n\nBelow 25°C\nIn a cool, dry place\nAway from moisture and direct sunlight\nIn the original packaging\nOut of reach of children and pets\n\nDo not use expired medicine.\n\nWhy Healthcare Professionals Choose This Triple Combination\n\nDoctors frequently recommend Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg because it addresses multiple aspects of diabetes management in a single formulation. By improving insulin secretion, reducing hepatic glucose production, and enhancing insulin sensitivity, it provides comprehensive glycemic control while simplifying treatment. When combined with a healthy lifestyle and regular medical follow-up, it can support long-term diabetes management and help reduce the risk of complications associated with uncontrolled blood sugar.\n\nConclusion\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is an effective prescription medication designed for adults with Type 2 Diabetes Mellitus who require stronger blood sugar management than single or dual therapy can provide. Its triple-action formula offers improved glycemic control, better insulin utilization, and convenient once-daily dosing. While highly effective, it should always be used under the guidance of a qualified healthcare professional, together with a balanced diet, regular physical activity, and routine blood sugar monitoring for the best long-term outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n1. What is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg used for?\n\nIt is prescribed to help adults with Type 2 Diabetes Mellitus control blood sugar when lifestyle changes and other oral medicines do not provide adequate glycemic control.\n\n2. How does this triple-combination tablet work?\n\nIt combines three medicines that increase insulin release after meals, reduce glucose production by the liver, and improve the body's sensitivity to insulin, resulting in better overall blood sugar control.\n\n3. Can this medicine be taken once daily?\n\nYes. Many patients take it once daily, but the exact dosage and timing should always follow the prescribing doctor's instructions.\n\n4. Should I take this tablet with food?\n\nYes. Taking it with meals helps reduce stomach-related side effects associated with metformin and improves tolerability.\n\n5. Can this medicine cure diabetes?\n\nNo. It helps control blood sugar levels but does not cure Type 2 Diabetes. Long-term treatment, healthy eating, exercise, and regular monitoring remain essential.\n\n6. What should I do if I miss a dose?\n\nTake the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together to make up for a missed dose.\n\n7. Can this medicine cause low blood sugar?\n\nOn its own, the risk is relatively low. However, the likelihood increases when it is used with insulin or sulfonylurea medicines, or if meals are skipped.\n\n8. Is this medicine safe for patients with kidney disease?\n\nPatients with kidney impairment require medical evaluation before using this medicine, particularly because metformin may not be suitable in severe kidney dysfunction.\n\n9. Can I drink alcohol while taking this medication?\n\nAlcohol intake should be limited or avoided, as excessive consumption may increase the risk of serious side effects, including lactic acidosis.\n\n10. Who should not use Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nIt should not be used without medical advice by individuals with Type 1 Diabetes, diabetic ketoacidosis, severe kidney disease, certain liver conditions, or a history of serious hypersensitivity to any of its ingredients. Always consult your healthcare provider before starting treatment.",
"price": 243.0,
"discountamount": 73.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2462,
"imageuri": "https://productimages.withfloats.com/actual/6a43bee3de301bd6de277db2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a43bee3de301bd6de277db2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-30T13:04:34Z",
"updatedon": "2026-06-30T13:04:34Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-100mg-metformin-hydrochloride-1000mg-sustained-release-pioglitazone-15-mg/2462",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN 3D 1000",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a06f0051c45b26e830ddf29",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "dapagliflozin 10 vildagliptin 100 metformin 1000",
"description": "Managing type 2 diabetes effectively requires the right combination of medicines, healthy eating habits, and an active lifestyle. Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a powerful triple-combination anti-diabetic medication designed to help control blood sugar levels in adults suffering from type 2 diabetes mellitus. This advanced formulation combines three clinically trusted medicines in one tablet to improve glycemic control and support long-term diabetic management.\n\nThis combination is commonly prescribed when blood sugar levels are not adequately controlled with a single medicine or dual therapy. It helps patients achieve better glucose regulation while reducing the risk of diabetes-related complications.\n\nWhat is Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a combination medication used for the treatment of Type 2 Diabetes Mellitus. It contains:\n\nDapagliflozin 10 mg\nVildagliptin SR 100 mg\nMetformin SR 1000 mg\n\nEach ingredient works through a different mechanism to provide comprehensive blood sugar control.\n\nThis medicine is generally recommended along with proper diet and exercise to improve overall diabetic management and reduce insulin resistance.\n\nComposition of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class of medicines. It works by removing excess glucose from the body through urine. This helps lower blood sugar levels naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels in the body. These hormones help regulate insulin secretion and reduce glucose production by the liver.\n\n3. Metformin SR 1000 mg\n\nMetformin is one of the most trusted anti-diabetic medicines worldwide. It reduces glucose production in the liver and improves insulin sensitivity in the body.\n\nThe sustained-release (SR) formulation ensures gradual release of medicine for long-lasting action and better patient compliance.\n\nHow Do Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets Work?\n\nThis triple combination provides multidimensional control over blood sugar levels.\n\nDapagliflozin Works By:\nRemoving excess sugar through urine\nLowering fasting blood glucose\nSupporting weight management\nVildagliptin Works By:\nIncreasing insulin release after meals\nReducing glucagon secretion\nImproving pancreatic function\nMetformin Works By:\nReducing liver glucose production\nImproving insulin sensitivity\nLowering intestinal glucose absorption\n\nTogether, these medicines help maintain stable blood glucose levels throughout the day.\n\nBenefits of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\nEffective Blood Sugar Control\n\nThe combination targets multiple pathways involved in diabetes, helping achieve better glycemic control.\n\nReduced Risk of Diabetes Complications\n\nProper diabetes management lowers the risk of:\n\nKidney problems\nNerve damage\nHeart disease\nVision complications\nWeight Management Support\n\nDapagliflozin helps remove excess glucose, which may contribute to mild weight reduction in some patients.\n\nImproved Insulin Sensitivity\n\nMetformin enhances insulin utilization by body tissues.\n\nBetter Patient Compliance\n\nThree medicines in a single tablet reduce pill burden and simplify treatment.\n\nSustained Release Formula\n\nThe SR formulation provides extended therapeutic action and minimizes fluctuations in blood sugar levels.\n\nUses of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n\nThis medicine is mainly prescribed for:\n\nType 2 Diabetes Mellitus\nUncontrolled diabetes despite dual therapy\nPatients requiring triple-drug glucose control\nImproving HbA1c levels\nManaging post-meal blood sugar spikes\n\nIt is generally not recommended for type 1 diabetes unless specifically advised by a healthcare professional.\n\nWho Can Take This Medicine?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets may be suitable for:\n\nAdults diagnosed with type 2 diabetes\nPatients with insulin resistance\nIndividuals requiring combination diabetic therapy\nPatients seeking convenient once-daily diabetic medication\n\nAlways use this medicine under medical supervision.\n\nDosage and Administration\nTake the tablet exactly as prescribed by your doctor.\nUsually taken once daily with meals.\nSwallow the tablet whole with water.\nDo not crush or chew sustained-release tablets.\nFollow dietary recommendations for best results.\n\nDosage may vary depending on blood sugar levels and patient response.\n\nPossible Side Effects\n\nLike all medicines, Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg tablets may cause some side effects.\n\nCommon Side Effects\nNausea\nDiarrhea\nFrequent urination\nHeadache\nStomach discomfort\nWeakness\nLess Common Side Effects\nUrinary tract infections\nGenital fungal infections\nDizziness\nLow blood sugar (especially with other anti-diabetic medicines)\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSevere dehydration\nDifficulty breathing\nSevere abdominal pain\nSigns of allergic reaction\nPersistent vomiting\n\nMost side effects are mild and improve as the body adjusts to the medicine.\n\nPrecautions and Warnings\n\nBefore taking this medicine, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart disease\nHistory of pancreatitis\nDehydration issues\nAlcohol dependence\nImportant Precautions\nStay hydrated while taking dapagliflozin.\nMonitor blood sugar regularly.\nAvoid excessive alcohol consumption.\nFollow a diabetic-friendly diet.\n\nPregnant and breastfeeding women should consult a doctor before use.\n\nDrug Interactions\n\nThis medicine may interact with:\n\nInsulin\nSulfonylureas\nDiuretics\nBlood pressure medicines\nCorticosteroids\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nStorage Instructions\nStore in a cool and dry place.\nKeep away from direct sunlight and moisture.\nStore below recommended room temperature.\nKeep out of reach of children.\n\nProper storage ensures medicine effectiveness and safety.\n\nWhy Choose Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets?\n\nThis advanced antidiabetic combination offers:\n\nTriple-action diabetes management\nLong-lasting blood sugar control\nConvenient dosing\nImproved patient adherence\nComprehensive glycemic regulation\n\nIt is widely preferred by healthcare professionals for patients requiring strong and reliable diabetic treatment.\n\nLifestyle Tips for Better Diabetes Management\n\nAlong with medication, patients should:\n\nMaintain a balanced diabetic diet\nExercise regularly\nMonitor blood glucose levels\nStay hydrated\nAvoid sugary foods\nFollow regular medical checkups\n\nHealthy lifestyle changes significantly improve treatment outcomes.\n\nFrequently Asked Questions\nIs Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets safe for long-term use?\n\nYes, when taken under medical supervision, it is generally considered safe for long-term diabetes management.\n\nCan this medicine help reduce HbA1c levels?\n\nYes, this combination is effective in lowering HbA1c and maintaining blood sugar control.\n\nDoes this medicine cause weight gain?\n\nDapagliflozin may support mild weight reduction in some patients.\n\nCan I stop the medicine once sugar levels improve?\n\nDo not stop taking the medicine without consulting your doctor.\n\nIs this medicine suitable for elderly patients?\n\nIt may be prescribed to elderly patients after proper medical evaluation.\n\nConclusion\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets are a highly effective triple-combination therapy for managing type 2 diabetes mellitus. By combining the benefits of dapagliflozin, vildagliptin, and metformin SR, this medicine provides comprehensive blood sugar control, improves insulin sensitivity, and helps reduce diabetes-related complications.",
"price": 375.0,
"discountamount": 113.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2422,
"imageuri": "https://productimages.withfloats.com/actual/6a06f00b91493d06f6e7fcdf.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a06f00b91493d06f6e7fcdf.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-15T10:05:57.462Z",
"updatedon": "2026-06-05T07:31:14.082Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-vildagliptin-100-metformin-1000/2422",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPAVILDA MET 10/100/1000",
"category": "DIABETIC RANGE",
"tags": [
"dapagliflozin 10 vildagliptin 100 metformin 1000",
"dapagliflozin vildagliptin metformin",
"dapagliflozin vildagliptin metformin combination",
"dapagliflozin vildagliptin metformin 1000",
"Dapagliflozin + Vildagliptin + Metformin Tablets",
"Buy Dapagliflozin + Vildagliptin + Metformin Tablets Online",
"Type 2 Diabetes Treatment Tablets",
"Blood Sugar Control Medicine with Dapagliflozin, Vildagliptin & Metformin",
"Triple Combination Anti-Diabetic Tablets",
"Best Diabetes Control Tablets for Type 2 Diabetes",
"Prescription Anti-Diabetic Medicine Tablets",
"Dapagliflozin 10 mg Vildagliptin 100 mg Metformin 1000 mg Product Image",
"Premium Quality Diabetic Care Tablets",
"Combination Diabetes Medicine for Glycemic Control",
"Type 2 Diabetes Management Tablets Online",
"Advanced Blood Sugar Control Tablets",
"Dapagliflozin Vildagliptin Metformin Tablets Supplier in India",
"Dapagliflozin Vildagliptin Metformin Tablets Manufacturer in India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69d4f4af8538099a3d49a36b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 500 mg (Extended Release) Tablets",
"description": "Managing type 2 diabetes effectively requires a combination of the right medication, lifestyle changes, and continuous monitoring. GLIDAPA TENMET 500, a powerful triple-combination tablet containing Dapagliflozin (10 mg), Teneligliptin (20 mg), and Metformin Hydrochloride (500 mg), is designed to provide comprehensive glycemic control for individuals suffering from type 2 diabetes mellitus.\n\nThis advanced formulation works through multiple mechanisms to regulate blood sugar levels, improve insulin sensitivity, and reduce glucose production, making it an ideal solution for patients who require combination therapy.\n\nHow GLIDAPA TENMET 500 Works\n\nGLIDAPA TENMET 500 combines three well-established antidiabetic agents, each targeting different pathways:\n\nDapagliflozin works by inhibiting SGLT2 receptors in the kidneys, promoting the excretion of excess glucose through urine.\nTeneligliptin increases incretin hormone levels, which stimulate insulin secretion and decrease glucagon release after meals.\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues.\n\nTogether, this triple-action formula ensures better blood sugar control throughout the day, especially for patients with uncontrolled diabetes on monotherapy.\n\nUses of GLIDAPA TENMET 500\n\nGLIDAPA TENMET 500 is primarily prescribed for:\n\nManagement of Type 2 Diabetes Mellitus\nPatients with inadequate glycemic control on dual therapy\nReducing fasting and postprandial blood glucose levels\nImproving insulin sensitivity\nSupporting weight management in diabetic patients\n\nIt is usually recommended along with a proper diet and regular exercise for optimal results.\n\nKey Benefits of GLIDAPA TENMET 500\n1. Triple Mechanism Action\n\nUnlike single or dual therapy drugs, this combination provides a three-way approach to diabetes control, targeting different physiological processes.\n\n2. Effective Blood Sugar Control\n\nIt helps maintain stable glucose levels throughout the day, reducing spikes after meals.\n\n3. Weight Management Support\n\nDapagliflozin aids in calorie loss through urine, which may help in weight reduction.\n\n4. Cardiovascular Benefits\n\nThis combination may help reduce cardiovascular risks associated with diabetes when used under medical supervision.\n\n5. Low Risk of Hypoglycemia\n\nCompared to some other antidiabetic medications, it has a relatively lower risk of causing dangerously low blood sugar levels.\n\n6. Improved Patient Compliance\n\nCombining three drugs in one tablet reduces pill burden and improves adherence.\n\nDosage and Administration\nTake GLIDAPA TENMET 500 as prescribed by your doctor\nUsually taken once daily with meals to reduce gastrointestinal side effects\nSwallow the tablet whole; do not crush or chew\nFollow your physician’s advice strictly for best results\nSide Effects of GLIDAPA TENMET 500\n\nLike all medications, this combination may cause some side effects. Most are mild and temporary.\n\nCommon Side Effects\nNausea or vomiting\nDiarrhea\nHeadache\nIncreased urination\nNasopharyngitis (cold-like symptoms)\nMild dehydration\nSerious Side Effects (Rare)\nUrinary tract infections\nGenital infections\nLactic acidosis (rare but serious, linked to Metformin)\nHypoglycemia (especially if combined with other medications)\nKidney function changes\n\nIf any severe symptoms occur, immediate medical attention is necessary.\n\nPrecautions and Warnings\nNot recommended for patients with severe kidney disease\nUse cautiously in elderly patients\nAvoid excessive alcohol consumption\nInform your doctor if you have liver, heart, or pancreatic conditions\nNot suitable for type 1 diabetes or diabetic ketoacidosis\n\nPregnant and breastfeeding women should consult a healthcare professional before use.\n\nWho Should Use GLIDAPA TENMET 500?\n\nThis medication is ideal for:\n\nAdults diagnosed with Type 2 Diabetes\nPatients requiring combination therapy\nIndividuals not achieving control with Metformin alone\nOverweight diabetic patients needing additional metabolic benefits\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nGLIDAPA TENMET 500 is a modern, highly effective triple-combination therapy designed to provide comprehensive control over type 2 diabetes. With the combined power of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride, it addresses multiple aspects of glucose metabolism, making it a preferred choice for healthcare professionals.\n\nIts benefits go beyond just blood sugar control—it also supports weight management, improves insulin sensitivity, and enhances overall metabolic health. However, like any medication, it should only be used under proper medical supervision to ensure safety and effectiveness.",
"price": 182.0,
"discountamount": 55.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2369,
"imageuri": "https://productimages.withfloats.com/actual/69d4f4b2203d41ae56676abb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69d4f4b2203d41ae56676abb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-07T12:12:31.371Z",
"updatedon": "2026-04-14T12:54:05.267Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-teneligliptin-20-mg-metformin-hydrochloride-500-mg-extended-release-tablets/2369",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIDAPA TENMET 500",
"category": "DIABETIC RANGE",
"tags": [
"dapagliflozin teneligliptin metformin combination uses",
"metformin teneligliptin dapagliflozin tablets for type 2 diabetes",
"buy dapagliflozin teneligliptin metformin tablets online India",
"dapagliflozin teneligliptin metformin tablet price wholesale",
"SGLT2 + DPP4 + Metformin combination tablet supplier",
"anti diabetic triple combination tablets wholesale",
"riple combination diabetes medicine manufacturer India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69affd814f6df2ce02d820ab",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Metformin Hydrochloride Prolonged Release",
"description": "Metformin Hydrochloride Prolonged Release Tablets for Effective Blood Sugar Control\n\nManaging diabetes requires a combination of proper medication, a balanced lifestyle, and regular monitoring of blood glucose levels. For individuals living with type 2 diabetes, maintaining stable blood sugar levels is essential to prevent complications and ensure overall health. SEIZMET 500, formulated with Metformin Hydrochloride Prolonged Release, is a trusted oral medication designed to help control blood sugar levels in adults diagnosed with type 2 diabetes mellitus.\n\nSEIZMET 500 works by improving the body's response to insulin and reducing the amount of glucose produced by the liver. Its prolonged-release formulation allows the medicine to work gradually throughout the day, providing consistent blood sugar control while reducing gastrointestinal discomfort that may occur with immediate-release forms of metformin.\n\nThis medication is widely recommended by healthcare professionals as a first-line treatment for type 2 diabetes, especially for patients who need effective glycemic control along with long-term metabolic support.\n\nProduct Description\n\nSEIZMET 500 is an oral antidiabetic medication containing Metformin Hydrochloride in a prolonged-release formulation. Metformin belongs to a class of medicines known as biguanides, which are commonly prescribed to manage type 2 diabetes.\n\nUnlike many diabetes medications that stimulate the pancreas to produce more insulin, Metformin works through multiple mechanisms that improve the body’s natural ability to regulate blood sugar. It reduces excess glucose production in the liver, increases insulin sensitivity, and enhances the uptake of glucose by muscles and tissues.\n\nThe prolonged-release (PR) technology used in SEIZMET 500 ensures that the medicine is released slowly into the bloodstream over time. This gradual release helps maintain stable blood sugar levels throughout the day and minimizes sudden spikes or fluctuations in glucose levels.\n\nSEIZMET 500 is typically prescribed along with dietary modifications, exercise, and regular monitoring of blood glucose levels to achieve optimal diabetes management.\n\nComposition\n\nEach tablet of SEIZMET 500 contains:\n\nMetformin Hydrochloride Prolonged Release – 500 mg\n\nThis controlled-release formulation provides sustained therapeutic action and improved patient tolerance.\n\nUses of SEIZMET 500\n\nSEIZMET 500 is primarily used for the treatment and management of type 2 diabetes mellitus. It helps control blood sugar levels in individuals whose glucose levels cannot be adequately managed through lifestyle changes alone.\n\n1. Treatment of Type 2 Diabetes\n\nThe primary use of SEIZMET 500 is to manage elevated blood sugar levels in adults diagnosed with type 2 diabetes.\n\n2. Improving Glycemic Control\n\nThe medication helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic stability.\n\n3. Supporting Insulin Sensitivity\n\nMetformin enhances the body's sensitivity to insulin, allowing cells to use glucose more effectively for energy.\n\n4. Prevention of Diabetes Complications\n\nBy maintaining proper blood sugar levels, SEIZMET 500 may help reduce the risk of complications such as nerve damage, kidney disease, vision problems, and cardiovascular conditions.\n\n5. Management of Insulin Resistance\n\nMetformin is known for its ability to reduce insulin resistance, which is a major factor contributing to type 2 diabetes.\n\nHow SEIZMET 500 Works\n\nSEIZMET 500 works through several mechanisms that help control blood glucose levels:\n\nReduces Liver Glucose Production\nThe liver produces glucose even when the body does not need it. Metformin helps decrease this excessive glucose production.\n\nImproves Insulin Sensitivity\nThe medication helps body tissues respond better to insulin, allowing glucose to enter cells more efficiently.\n\nEnhances Glucose Utilization\nMuscles and other tissues use glucose more effectively for energy.\n\nDecreases Intestinal Glucose Absorption\nMetformin slows down the absorption of glucose from the digestive tract after meals.\n\nThe prolonged-release technology ensures that these actions occur steadily throughout the day.\n\nKey Benefits of SEIZMET 500\n1. Effective Blood Sugar Control\n\nSEIZMET 500 helps maintain healthy blood glucose levels, reducing the risk of hyperglycemia.\n\n2. Sustained Drug Release\n\nThe prolonged-release formulation provides gradual drug release, ensuring consistent therapeutic effects.\n\n3. Lower Risk of Hypoglycemia\n\nUnlike some diabetes medications, metformin rarely causes dangerously low blood sugar when used alone.\n\n4. Improved Insulin Sensitivity\n\nSEIZMET 500 improves the body's response to insulin, allowing glucose to be used more efficiently.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps maintain stable glucose levels and supports overall metabolic health.\n\n6. Reduced Gastrointestinal Side Effects\n\nThe prolonged-release formulation helps minimize stomach-related side effects commonly associated with immediate-release metformin.\n\n7. Weight-Neutral or Weight-Friendly\n\nMetformin may help prevent weight gain and in some cases may support mild weight reduction, which can benefit people with type 2 diabetes.\n\nHow to Use SEIZMET 500\n\nTo achieve the best results, SEIZMET 500 should be taken according to the instructions provided by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with meals to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush, chew, or break the prolonged-release tablet.\n\nFollow the dosage and schedule prescribed by your doctor.\n\nMaintain a healthy diet and regular exercise routine.\n\nConsistency in taking the medication is essential for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, SEIZMET 500 may cause side effects in some individuals. Most side effects are mild and temporary, especially during the early stages of treatment.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nStomach upset\n\nLoss of appetite\n\nMild abdominal discomfort\n\nThese symptoms often improve as the body adjusts to the medication.\n\nLess Common Side Effects\n\nMetallic taste in the mouth\n\nVitamin B12 deficiency with long-term use\n\nMild weakness or fatigue\n\nRare but Serious Side Effects\n\nLactic acidosis, a rare but serious condition associated with metformin use in patients with severe kidney problems\n\nSevere allergic reactions\n\nIf symptoms such as unusual muscle pain, difficulty breathing, severe weakness, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking SEIZMET 500, inform your healthcare provider if you have:\n\nKidney disease\n\nLiver disorders\n\nHeart conditions\n\nSevere infections\n\nA history of alcohol abuse\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nRegularly monitor blood sugar levels.\n\nAttend routine medical checkups.\n\nInform your doctor about any other medications you are taking.\n\nLifestyle Recommendations for Better Results\n\nMedication alone may not be enough to manage diabetes effectively. Individuals taking SEIZMET 500 should also focus on healthy lifestyle habits such as:\n\nMaintaining a balanced and nutritious diet\n\nEngaging in regular physical activity\n\nMonitoring blood sugar levels regularly\n\nMaintaining a healthy body weight\n\nFollowing medical advice and attending regular health checkups\n\nThese steps help maximize the benefits of the medication and support overall health.\n\nConclusion\n\nType 2 diabetes is a long-term condition that requires consistent management to maintain healthy blood sugar levels and prevent complications. SEIZMET 500, containing Metformin Hydrochloride Prolonged Release, offers an effective and reliable treatment option for individuals seeking better glucose control.",
"price": 31.0,
"discountamount": 9.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2324,
"imageuri": "https://productimages.withfloats.com/actual/69affdab1344531582e8f29c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69affdab1344531582e8f29c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-03-10T11:16:17.511Z",
"updatedon": "2026-03-14T12:11:16.322Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-prolonged-release/2324",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SEIZMET 500",
"category": "DIABETIC RANGE",
"tags": [
"metformin hydrochloride prolonged release tablets",
"metformin hydrochloride slow release tablets",
"prolonged release metformin 500 mg tablets",
"metformin hcl pr tablets for diabetes",
"metformin hydrochloride controlled release tablet",
"metformin hydrochloride 1000 mg prolonged release",
"diabetes management tablets metformin prolonged release",
"medicine for type 2 diabetes metformin pr tablets",
"slow release metformin tablets for high blood sugar",
"extended release metformin tablets for blood sugar management",
"metformin hydrochloride extended release for insulin resistance",
"buy metformin hydrochloride prolonged release tablets",
"metformin pr tablets price",
"SEIZMET 500 metformin hydrochloride prolonged release price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "699bfe45e844b0fb29d2bbad",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 100 Pioglitazone 15 Metformin 500",
"description": "Product Name: ST GLIPTIN 3D 500\nComposition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg\n\nST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action.\n\nThis triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes.\n\nProduct Description\n\nST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation:\n\nSitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.\n\nPioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively.\n\nMetformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake.\n\nBy combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency.\n\nUses of ST GLIPTIN 3D 500\n\nST GLIPTIN 3D 500 is primarily indicated for:\n\nManagement of Type 2 Diabetes Mellitus\n\nImproving glycemic control in adults\n\nPatients inadequately controlled on metformin alone\n\nIndividuals requiring triple oral therapy\n\nReducing fasting and postprandial blood glucose levels\n\nSupporting long-term HbA1c reduction\n\nIt is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management.\n\nHow ST GLIPTIN 3D 500 Works\n\nType 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects:\n\nEnhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia.\n\nImproves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin.\n\nReduces glucose production (Metformin) – Decreases sugar release from the liver.\n\nThis comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control.\n\nKey Benefits of ST GLIPTIN 3D 500\n1. Triple Mechanism Advantage\n\nCombines three different classes of antidiabetic agents for broader and more effective blood sugar management.\n\n2. Improved HbA1c Reduction\n\nHelps significantly lower HbA1c levels when compared to monotherapy.\n\n3. Reduced Pill Burden\n\nThree medications in one tablet improve patient compliance and convenience.\n\n4. Better Postprandial Control\n\nHelps manage blood glucose spikes after meals.\n\n5. Insulin Sensitivity Enhancement\n\nPioglitazone improves peripheral glucose utilization.\n\n6. Lower Risk of Hypoglycemia\n\nSitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately.\n\n7. Suitable for Long-Term Management\n\nDesigned for chronic use under medical supervision.\n\nDosage and Administration\n\nThe dosage should be taken strictly as prescribed by a healthcare professional.\n\nUsually administered once daily with meals to reduce gastrointestinal discomfort.\n\nSwallow the tablet whole with water.\n\nDo not crush or chew unless directed by a doctor.\n\nRegular monitoring of blood glucose and HbA1c levels is recommended during therapy.\n\nPossible Side Effects\n\nLike all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nUpper respiratory symptoms\n\nLess Common but Important:\n\nWeight gain (associated with Pioglitazone)\n\nFluid retention or edema\n\nLow blood sugar (when combined with other antidiabetic agents)\n\nVitamin B12 deficiency (long-term Metformin use)\n\nRare but Serious:\n\nLactic acidosis (rare, associated with Metformin)\n\nPancreatitis (rare, associated with Sitagliptin)\n\nLiver function abnormalities\n\nPatients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties.\n\nPrecautions and Warnings\n\nNot recommended for Type 1 diabetes.\n\nUse cautiously in patients with renal impairment.\n\nLiver function monitoring may be required.\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about any existing heart conditions.\n\nPregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight.\n\nKeep out of reach of children.\n\nWhy Choose ST GLIPTIN 3D 500?\n\nST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden.\n\nThe triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes.\n\nConclusion\nST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.",
"price": 222.0,
"discountamount": 67.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2311,
"imageuri": "https://productimages.withfloats.com/actual/699bfe47d849febb9bcc2d46.png",
"tileimageuri": "https://productimages.withfloats.com/tile/699bfe47d849febb9bcc2d46.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-23T07:14:13.494Z",
"updatedon": "2026-03-13T11:04:02.141Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100-pioglitazone-15-metformin-500/2311",
"availableunits": -1.0,
"iscodavailable": true,
"isprepaidonlineavailable": true,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN 3D 500",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin 100 Pioglitazone 15 Metformin 500 tablet uses",
"Sitagliptin Pioglitazone Metformin triple therapy dosage",
"Sitagliptin 100 mg Pioglitazone 15 mg Metformin 500 mg benefits",
"Triple combination tablet for type 2 diabetes control",
"Sitagliptin Pioglitazone Metformin side effects in adults",
"How to take Sitagliptin Pioglitazone Metformin tablet",
"Sitagliptin Metformin Pioglitazone price in India",
"Buy Sitagliptin 100 Pioglitazone 15 Metformin 500 online",
"Order Sitagliptin Pioglitazone Metformin tablets",
"Sitagliptin 100 Pioglitazone 15 Metformin 500 price",
"Sitagliptin triple combination bulk purchase"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "694e56c05837f90c86a7eb8c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "empagliflozin linagliptin and metformin",
"description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.",
"price": 220.0,
"discountamount": 66.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2257,
"imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png",
"tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-26T09:34:56.604Z",
"updatedon": "2026-03-13T10:59:31Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "LINALIGIP EMPAMET",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin 10 mg",
"empagliflozin 25 mg",
"empagliflozin 10 mg uses in hindi",
"empagliflozin 10 mg tablet.",
"type 2 diabetes mellitus.",
"linagliptin",
"Linagliptin 5 mg",
"linagliptin 5 mg uses",
"linagliptin tablet uses",
"Linagliptin 5 mg price",
"Empagliflozin, an SGLT2 inhibitor.",
"Metformin ER reduces hepatic glucose production and improves insulin.",
"LINALIGIP EMPAMET revolutionizes type 2 diabetes.",
"empagliflozin linagliptin and metformin tablets",
"empagliflozin linagliptin metformin combination tablet",
"empagliflozin linagliptin metformin tablets uses",
"empagliflozin linagliptin metformin triple combination",
"empagliflozin linagliptin metformin dosage strength",
"empagliflozin linagliptin metformin sustained release tablet",
"empagliflozin linagliptin metformin medicine for diabetes",
"empagliflozin linagliptin metformin tablet uses",
"empagliflozin linagliptin metformin benefits",
"empagliflozin linagliptin metformin for type 2 diabetes",
"empagliflozin linagliptin metformin blood sugar control",
"empagliflozin linagliptin metformin weight loss benefit",
"what is empagliflozin linagliptin metformin tablet",
"how does empagliflozin linagliptin metformin work",
"empagliflozin linagliptin metformin tablet price in india",
"empagliflozin linagliptin metformin tablet dosage",
"empagliflozin linagliptin metformin before or after food"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68d51d9a26579f4bc195771a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glimepiride voglibose metformin",
"description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ",
"price": 263.0,
"discountamount": 80.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2182,
"imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:46:50.098Z",
"updatedon": "2026-03-13T10:35:41.824Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS MV1 0.2",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride voglibose metformin tablets",
"glimepiride voglibose metformin combination",
"glimepiride voglibose metformin dosage",
"glimepiride voglibose metformin uses",
"glimepiride voglibose metformin composition",
"glimepiride voglibose metformin tablets ip",
"glimepiride voglibose metformin triple combination",
"glimepiride voglibose metformin for type 2 diabetes",
"triple drug combination for type 2 diabetes",
"diabetes medicine for high fasting and pp sugar",
"medicine for uncontrolled diabetes type 2",
"combination tablets for diabetes management",
"combination tablets for diabetes management",
"when to take glimepiride voglibose metformin tablets",
"who should take glimepiride voglibose metformin",
"benefits of glimepiride voglibose metformin tablets",
"side effects of glimepiride voglibose metformin"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66694121b6d3f41940ea70a2",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "acamprosate calcium tablets 333 mg",
"description": "ACAMPURE 333 \nAcamprosate calcium (333mg)\nIntroduction\nACAMPURE 333 contains Acamprosate Calcium (333mg), a medication specifically designed to support individuals in their recovery from alcohol dependence. Acamprosate is used as part of a comprehensive treatment program that includes counseling and support. It works by helping to restore the chemical balance in the brain that is disrupted by long-term alcohol use, reducing cravings and the risk of relapse.\nKey Ingredient and Its Benefits\nAcamprosate Calcium (333mg)\nNeurotransmitter Balance: Acamprosate works by modulating the activity of neurotransmitters in the brain, helping to stabilize the chemical imbalances caused by chronic alcohol consumption. This can reduce cravings and the desire to drink.\nCraving Reduction: By restoring the balance of GABA (gamma-aminobutyric acid) and glutamate neurotransmitters, Acamprosate helps to reduce the intense cravings and urges to consume alcohol, making it easier for individuals to maintain sobriety.\nSupport During Abstinence: Acamprosate is most effective when used as part of a comprehensive treatment plan that includes psychological support and counseling. It supports individuals in maintaining abstinence from alcohol.\nBenefits of ACAMPURE 333\nReduces Cravings: ACAMPURE 333 helps reduce the intense cravings for alcohol, making it easier for individuals to stay abstinent.\nSupports Brain Health: By restoring neurotransmitter balance, Acamprosate aids in repairing the damage caused by long-term alcohol use, supporting overall brain health.\nFacilitates Recovery: When used as part of a comprehensive treatment plan, ACAMPURE 333 can significantly improve the chances of successful long-term recovery from alcohol dependence.\nImproves Quality of Life: By helping individuals maintain abstinence, ACAMPURE 333 can improve overall quality of life, including better physical health, mental clarity, and emotional stability.\nDosage and Administration\nDosage\nRecommended Dosage: The typical dosage of ACAMPURE 333 is two tablets taken three times daily, depending on the individual's needs and the healthcare provider's recommendation. The exact dosage should be determined by a healthcare provider.\nAdministration\nOral Use: Swallow the tablets whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take ACAMPURE 333 at the same times each day to maintain an even level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n Order NOW\n",
"price": 88.0,
"discountamount": 26.4,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"food",
"33mg",
"Life",
"GABA",
"part",
"risk",
"level",
"urges",
"water",
"needs",
"EMAIL",
"Order",
"damage",
"desire",
"relapse",
"chances",
"Benefits",
"activity",
"sobriety",
"Oral Use",
"ACAMPURE",
"same times",
"Abstinence",
"counseling",
"medication",
"full glass",
"Consistency",
"bloodstream",
"information",
"two tablets",
"individuals",
"sterispharma",
"sterisonline",
"Introduction",
"exact dosage",
"CALL/WHATSAPP",
"recommendation",
"mental clarity",
"Key Ingredient",
"typical dosage",
"overall quality",
"physical health",
"optimal results",
"chemical balance",
"intense cravings",
"Craving Reduction",
"Recommended Dosage",
"alcohol dependence",
"healthcare provider",
"emotional stability",
"chemical imbalances",
"Acamprosate calcium",
"overall brain health",
"long-term alcohol use",
"Administration Dosage",
"psychological support",
"gamma-aminobutyric acid",
"Neurotransmitter Balance",
"glutamate neurotransmitters",
"chronic alcohol consumption",
"comprehensive treatment plan",
"successful long-term recovery",
"comprehensive treatment program"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1751,
"imageuri": "https://productimages.withfloats.com/actual/66694123475de163fe8ce227.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66694123475de163fe8ce227.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-12T06:33:05.035Z",
"updatedon": "2026-03-12T08:33:13.139Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//acamprosate-calcium-tablets-333-mg/1751",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ACAMPURE 333 ",
"category": "NEUROLOGY RANGE",
"tags": [
"ACAMPURE 333",
"Acamprosate calcium (333mg)",
"acamprosate calcium 333 mg price",
"acamprosate calcium 333 mg side effects",
"Acamprosate 333 mg uses",
"acamprosate calcium tablets 333 mg dosage guide",
"how to take acamprosate calcium tablets 333 mg",
"acamprosate calcium tablets 333 mg side effects guide",
"acamprosate calcium tablets 333 mg for alcohol dependence treatment",
"acamprosate calcium tablets 333 mg for relapse prevention",
"acamprosate calcium tablets 333 mg long term use",
"acamprosate calcium tablets 333 mg after detox",
"acamprosate calcium tablets 333 mg missed dose advice",
"acamprosate calcium tablets 333 mg tablet appearance",
"acamprosate calcium tablets 333 mg uses in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}